FDLI's Introduction to Drug Law & Regulation

The Food and Drug Law Institute is committed to providing high quality education and a neutral forum for the generation of ideas and discussion of law and public policy for its legal, policy and regulatory communities.

Teresa Rea is speaking on Hatch-Waxman Issues - The Abbreviated NDA, 505(b)(2) applications and patent and other exclusivity issues. She is also leading a breakout section on Brand vs. Generic Issues: The Strategic Battle for the marketplace.